Evidence map›Paper›PMID 25687282›Full record

ArticleThe Journal of experimental medicine2015

Coupling of T cell receptor specificity to natural killer T cell development by bivalent histone H3 methylation.

Marc-Werner Dobenecker, Jong Kyong Kim, Jonas Marcello, Terry C Fang, Rab Prinjha, Remy Bosselut, Alexander Tarakhovsky

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Signals for antigen-independent differentiation of memory CD8Cellular and molecular life sciences : CMLS · 2021
    Review
  12. Review
  13. Article
  14. Review
  15. The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Marc-Werner DobeneckerLaboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065 dobenem@rockefeller.edu tarakho@rockefeller.edu.
Jong Kyong KimLaboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Jonas MarcelloLaboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065.
Terry C FangLaboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065.
Rab PrinjhaEpinova DPU, Immuno-Inflammation Therapy Area, GlaxoSmithKline R&D, Medicines Research Centre, Stevenage SG1 2NY, England, UK.
Remy BosselutLaboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Alexander TarakhovskyLaboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, New York, NY 10065 dobenem@rockefeller.edu tarakho@rockefeller.edu.
Rockefeller University · USNational Cancer Institute · USGlaxoSmithKline (United Kingdom) · GB

Funding

Genetic Analysis of T-cell DifferentiationZIABC010671 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BOSSELUT, REMY · 2009 to 2025
$34.3M
Control of inflammation by bromodomain containing proteinsR01GM112811 · NIGMS · ROCKEFELLER UNIVERSITY · PI TARAKHOVSKY, ALEXANDER · 2015 to 2018
$2.0M
NIGMS NIH HHS R01 GM112811
6 · The paper itself

Abstract

The fidelity of T cell immunity depends greatly on coupling T cell receptor signaling with specific T cell effector functions. Here, we describe a chromatin-based mechanism that enables integration of TCR specificity into definite T cell lineage commitment. Using natural killer T cells (iNKT cell) as a model of a T cell subset that differentiates in response to specific TCR signaling, we identified a key role of histone H3 lysine 27 trimethylation (H3K27me3) in coupling iNKT cell TCR specificity with the generation of iNKT cells. We found that the Zbtb16/PLZF gene promoter that drives iNKT cell differentiation possesses a bivalent chromatin state characterized by the simultaneous presence of negative and positive H3K27me3 and H3K4me3 modifications. Depletion of H3K27me3 at the Zbtb16/PLZF promoter leads to uncoupling of iNKT cell development from TCR specificity and is associated with accumulation of iNKT-like CD4(+) cells that express a non-iNKT cell specific T cell repertoire. In turn, stabilization of H3K27me3 leads to a drastic reduction of the iNKT cell population. Our data suggest that H3K27me3 levels at the bivalent Zbtb16/PLZF gene define a threshold enabling precise coupling of TCR specificity to lineage commitment.

Indexed as

T-Cell Antigen Receptor SpecificityAnimalsCD4 AntigensCD8-Positive T-LymphocytesChromatinEnhancer of Zeste Homolog 2 ProteinHistone DemethylasesHistonesJumonji Domain-Containing Histone DemethylasesKruppel-Like Transcription FactorsLysineMethylationMice, Inbred C57BLMice, TransgenicNatural Killer T-CellsPolycomb Repressive Complex 2CD4 AntigensChromatinEnhancer of Zeste Homolog 2 ProteinEzh2 protein, mouseHistone DemethylasesHistonesJumonji Domain-Containing Histone DemethylasesKdm6b protein, mouseKruppel-Like Transcription FactorsLysinePolycomb Repressive Complex 2Promyelocytic Leukemia Zinc Finger ProteinReceptors, Antigen, T-CellUtx protein, mouseZbtb16 protein, mouse

Identifiers

PMID25687282
PMCPMC4354372
OpenAlexW2171859250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.